supplement evidence

What does the evidence say about Acetyl L Carnitine Supplementation Cognitive Function Meta-Analysis?

Updated October 2026

Quick Answer

Acetyl L Carnitine Supplementation Cognitive Function Meta-Analysis has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: Emerging evidence indicates that fatty acid oxidation is impaired in both patients with AD and AD animal models.

Key Takeaways

  • 01Emerging evidence indicates that fatty acid oxidation is impaired in both patients with AD and AD animal models. [Xie Y (2026)]
  • 02We then screened GEO datasets to identify AD-associated genes involved in fatty acid metabolic dysregulation, identifying ACACB as a candidate target. [Xie Y (2026)]
  • 03In APP/PS1 mice, OA improved cognitive performance and reduced Aβ plaque deposition, accompanied by decreased ACACB and increased CPT1A expression in brain tissue. [Xie Y (2026)]
  • 04Background Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder. [Xie Y (2026)]
The current Migaku evidence database contains 2 reusable source documents for Acetyl L Carnitine Supplementation Cognitive Function Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Emerging evidence indicates that fatty acid oxidation is impaired in both patients with AD and AD animal models. [Xie Y (2026); evidence level 4] - We then screened GEO datasets to identify AD-associated genes involved in fatty acid metabolic dysregulation, identifying ACACB as a candidate target. [Xie Y (2026); evidence level 4] - In APP/PS1 mice, OA improved cognitive performance and reduced Aβ plaque deposition, accompanied by decreased ACACB and increased CPT1A expression in brain tissue. [Xie Y (2026); evidence level 4] - Background Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder. [Xie Y (2026); evidence level 4] - Additionally, weight loss has been associated with reduced inflammation and improved quality of life in FM patients. [Badaeva A (2024); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Learn next

Keep learning from this answer

GuideAshwagandha: What the Evidence Actually Says About Stress and CortisolLegacy library material — check the original sources.GuideMagnesium Glycinate benefits: what does the evidence sayLegacy library material — check the original sources.GuideProbiotics: What the Evidence Actually Supports (and What It Doesn't)Legacy library material — check the original sources.GuideL-Theanine: How It Works, What the Evidence Says, and How to Dose ItLegacy library material — check the original sources.DataAcetyl L Carnitine Supplementation Cognitive Function Meta-Analysis Evidence TableLegacy library material — check the original sources.DataAcetyl-L-Carnitine Mental Fatigue Randomized Trial Evidence TableLegacy library material — check the original sources.DataFermented Ginseng Fatigue Randomized Trial Evidence TableLegacy library material — check the original sources.

Sources

  1. Oleic acid improves pathological changes in Aβ1-42-induced astrocytes and Alzheimer's disease mouse models through PKA/ACACB/CPT1A.
  2. Neuronutritional Approach to Fibromyalgia Management: A Narrative Review.